mesalamine has been researched along with transforming growth factor beta in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Flisiak, R; Prokopowicz, D; Wiercińska-Drapało, A | 1 |
| Baumgart, DC; Dignass, AU; Sturm, A; Vierziger, K; Wiedenmann, B | 1 |
| Chen, J; Chen, JJ; Ding, WQ; Qiu, ZB; Rong, L; Yang, HJ; Zhong, L | 1 |
| Chang, B; Dai, C; Gao, N; Jiang, M; Liu, WX; Sang, LX | 1 |
| El-Armouche, A; Emig, R; Hoffmann, M; Kant, TA; Klapproth, E; Künzel, K; Künzel, SR; Newe, M; Peyronnet, R; Rausch, JSE; Ravens, U; Schubert, M; Winter, L | 1 |
| Bai, B; Han, L; Hu, C; Li, H; Liu, X; Mei, Q; Mei, Y; Xu, J | 1 |
6 other study(ies) available for mesalamine and transforming growth factor beta
| Article | Year |
|---|---|
Effect of ulcerative colitis treatment on transforming growth factor beta(1) in plasma and rectal mucosa.
Topics: Administration, Oral; Adult; Aged; Colitis, Ulcerative; Female; Humans; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Prednisone; Rectum; Severity of Illness Index; Sulfasalazine; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Flow Cytometry; In Vitro Techniques; Intestinal Mucosa; Mesalamine; Rats; Transforming Growth Factor beta; Wound Healing; Wounds and Injuries | 2005 |
Effect of recombinant Lactobacillus casei expressing interleukin-10 in dextran sulfate sodium-induced colitis mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Dextran Sulfate; Female; Interferon-gamma; Interleukin-10; Lacticaseibacillus casei; Mesalamine; Mice; Mice, Inbred BALB C; NF-kappa B; PPAR gamma; Recombinant Proteins; Severity of Illness Index; Transforming Growth Factor beta | 2013 |
Heat-killed VSL#3 ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in rats.
Topics: Acute Disease; Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Hot Temperature; Interleukin-23; Interleukin-6; Male; Mesalamine; Phosphorylation; Probiotics; Rats; Rats, Sprague-Dawley; RNA, Messenger; Severity of Illness Index; STAT3 Transcription Factor; Transforming Growth Factor beta | 2013 |
Repurposing mesalazine against cardiac fibrosis in vitro.
Topics: Actins; Cardiotonic Agents; Cell Differentiation; Cell Line; Collagen Type I; Drug Repositioning; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Humans; Mesalamine; Myocardium; Myofibroblasts; NF-kappa B; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta | 2021 |
Molecular mechanism of the TGF‑β/Smad7 signaling pathway in ulcerative colitis.
Topics: Animals; Cadherins; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Female; Intestinal Mucosa; Male; Mesalamine; Mice, Inbred C57BL; Myosin-Light-Chain Kinase; Occludin; Peroxidase; Severity of Illness Index; Signal Transduction; Smad7 Protein; Tight Junctions; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein | 2022 |